Navigation Links
Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations
Date:5/15/2008

Blood pressure reductions demonstrated in Blacks, Hispanics/Latinos, People

with Diabetes and Obese Individuals

PARSIPPANY, N.J., May 15 /PRNewswire/ -- Daiichi Sankyo, Inc., announced today that data presented at the American Society of Hypertension's Twenty- Third Annual Scientific Meeting (ASH 2008) in New Orleans demonstrated that the powerful combination drug AZOR(TM) (amlodipine and olmesartan medoxomil) safely and effectively helped patients across several major subpopulations lower their blood pressure (BP). An analysis of patient subgroups from the pivotal registrational trial demonstrated the efficacy of AZOR in several key difficult to treat patient groups including people of African and Hispanic/Latino decent, people with high body mass index (BMI) and those with diabetes.

The subgroup analyses were based on data from a pivotal, randomized, double-blind, placebo-controlled factorial design study conducted in 1,940 pts with mild to severe hypertension (SeDBP)(*) 95-120 mm Hg) to determine if amlodipine (AML) 5-10mg/day plus olmesartan (OM) 10-40 mg/day for eight weeks is more efficacious in reducing BP versus monotherapy components. The groups were chosen because each population generally have either poor control rates (Blacks and Hispanic/Latinos),(1)(2) are difficult to control (people with high BMI)(3) or require lower blood pressure to achieve control (those with diabetes).(4)

"As we know, hypertension affects many people from all walks of life," said Suzanne Oparil, M.D., Director, Vascular Biology & Hypertension Program, University of Alabama at Birmingham, an investigator in the study and President of ASH. "No two patients are alike, nor do any two people present in the exact same way. This study has demonstrated that AZOR is an important tool for physicians to consider when treating hypertensive patients of different ethnicities and health characteristics, as well as the more difficult to treat populat
'/>"/>

SOURCE Daiichi Sankyo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
2. Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95% and Halts Metastasis in a Model of Hormone-Refractory Prostate Cancer
3. CV Therapeutics Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
4. Recent Studies Suggest Popular Diet Pill Relacore Reduces Acne Breakouts
5. Minimally Invasive Treatment Reduces Shoulder Pain From Tendonitis
6. Smokefree Workplace Law Reduces Heart Attacks 59% Among Nonsmokers, New Research Shows
7. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
8. CV Therapeutics Anti-Ischemic Agent Ranexa(R) Significantly Reduces HbA1c and Other Markers of Diabetes in MERLIN TIMI-36
9. VIA Pharmaceuticals Presents Data at American Heart Association Meeting Showing VIA-2291 Significantly Reduces Inflammation in Preclinical Model of Atherosclerosis
10. Study Finds Starion Instruments Tissue Welding Technology Reduces Pain and Bleeding in Tonsillectomy Patients
11. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 2014   Hospira, Inc. (NYSE: ... and infusion technologies, today announced that the company will ... on Wednesday, Jan. 14, 2015, in San Francisco.  ... at 10:30 a.m. Pacific time on Wednesday, Jan. 14, ... through a live audiocast accessible via the Investor Relations ...
(Date:12/19/2014)... CARDIFF-BY-THE-SEA, Calif. , Dec. 19, ... SRNE ;  Sorrento), an oncology company developing new ... Inc., a privately-held immuno-oncology company developing proprietary Neukoplast ... based therapy, announced today that the companies have ... next generation CAR-TNK™ (pronounced as "Car-Tank") immunotherapies for ...
(Date:12/19/2014)... , Dec. 18, 2014  Sage Analytics ( ... of equipment for the testing of marijuana potency ... the new Luminary™ Profiler, the industry,s first product ... in a cost-effective, portable unit. Designed ... needs of the cannabis industry, the Luminary™ Profiler ...
Breaking Medicine Technology:Sorrento and Conkwest Announce Exclusive Global Collaboration 2Sorrento and Conkwest Announce Exclusive Global Collaboration 3Sorrento and Conkwest Announce Exclusive Global Collaboration 4Sorrento and Conkwest Announce Exclusive Global Collaboration 5Sage Analytics Develops Breakthrough System for Potency Testing of Cannabis Products 2
... Pa., June 25, 2007 /PRNewswire-FirstCall/ --,Genaera Corporation ... of trodusquemine (MSI-1436) for the treatment of ... (ADA) 67th,Scientific Sessions, June 22-25 in Chicago, ... lead author of Abstract #1801-P,presented, "Trodusquemine is ...
... blood sugar reductions seen across range of,patient populations, ... high risk of developing diabetes , * Galvus ... efficacy in combination with commonly used diabetes,medicines , ... studies showing,incidence of side effects similar to placebo ...
Cached Medicine Technology:Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 2Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 3Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 4New Data from Multiple Studies Show Galvus Delivers Consistent and,Robust Blood Sugar Control in Patients with Type 2 Diabetes 2New Data from Multiple Studies Show Galvus Delivers Consistent and,Robust Blood Sugar Control in Patients with Type 2 Diabetes 3New Data from Multiple Studies Show Galvus Delivers Consistent and,Robust Blood Sugar Control in Patients with Type 2 Diabetes 4New Data from Multiple Studies Show Galvus Delivers Consistent and,Robust Blood Sugar Control in Patients with Type 2 Diabetes 5New Data from Multiple Studies Show Galvus Delivers Consistent and,Robust Blood Sugar Control in Patients with Type 2 Diabetes 6
(Date:12/21/2014)... 21, 2014 The number of Mirena ... consolidated litigation underway in New Jersey, Bernstein Liebhard LLP ... 1,375 claims involving the birth control IUD have now ... were filed by women who allege spontaneous migration of ... uterine perforations and other complications they were inadequately warned ...
(Date:12/21/2014)... Tiburon, CA (PRWEB) December 21, 2014 ... and resolved performance issues in hundreds of emergency departments ... patient satisfaction. Its findings have been translated into an ... hospital leaders to correct deficiencies and enhance the patient ... of outsourced emergency physician staffing and management services for ...
(Date:12/21/2014)... CannabisClassifieds.com celebrates marijuana’s new legal place at the table ... kind, the site has provided its faithful users with everything ... It uniquely combines the benefits of platforms like Craigslist, ... the masses. Assuring the potent herb’s followers it’s well ... approval. , Shane Chattin, Owner of Cannabis Classifieds ...
(Date:12/20/2014)... BambooIndustry.com is a leading eco-friendly ... announced its bamboo flooring promotion for the coming ... certified suppliers, and offers the best bamboo products ... current promotion, all customers can enjoy a special ... they know BambooIndustry.com from press releases. , The ...
(Date:12/20/2014)... 2014 Dress company LunaDress has recently announced ... its Christmas Sale, offering big discounts on all of its ... an idea to own a perfect wedding gown. If you ... dress, then come to LunaDress. Many different wedding dress styles ... our website now and enjoy the current special offer, up ...
Breaking Medicine News(10 mins):Health News:Mirena Lawsuits Approach 1,400 in Bergen County Litigation, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuits Approach 1,400 in Bergen County Litigation, Bernstein Liebhard LLP Reports 3Health News:NES Health Launches Stipend Program for Emergency Physicians in Training to Financially Assist Emergency Department Doctors While They Learn 2Health News:CannabisClassifieds.com Maintains its “Craigslist for Cannabis” Standing with Website Re-launch 2Health News:Eco-friendy Bamboo Flooring Manufacturer BambooIndustry.com Introduces Its Bamboo Flooring Promotion for 2015 2Health News:2015 Collection of Wedding Dresses from LunaDress Online on Sale Now 2
... Clinic researchers who study the role nanoparticles may play in ... stones, will lead a symposium on how these super-small particles ... April 8 at the Experimental Biology conference in San Diego. ... E. coli, but recent advances in microscopy have allowed researchers ...
... April 2, 2008 Business Health,Services (BHS) has ... PDHI,s ConXus health improvement platform to deliver the ... service,levels., BHS is a workplace wellness and ... BHS is an integrated combination of,workplace wellness, employee ...
... Goosie, LLC,announced today that they will be ... donation of 15% of all online sales for ... to the special discount program,they are offering for ... 19, 2008 ( http://www.cnbc.com/id/23706189 ). Goosie is the ...
... Bad Reactions to FDA Safety,Program, WASHINGTON, April 2, 2008 ... Americans who have ever taken a,prescription drug experienced a side ... but the majority of consumers don,t know they can,report these ... safety problems., To help make the public aware of ...
... More people suffer from overweight, high blood pressure ... West Germany. This is the result of a ... the current edition of the Deutsches rzteblatt International ... http://www.aerzteblatt-international.de/v4/archiv/pdf.asp?id=59482 ) , The so-called metabolic syndrome describes ...
... Imaging technique could help surgeons remove all ... Stanford University researchers have developed a new imaging system ... doctors view details 1,000 times smaller than previously possible. ... the body to serve as beacons for lasers, according ...
Cached Medicine News:Health News:Symposium to explore role nanoparticles may play in disease 2Health News:Business Health Services Deploys the PDHI ConXus Health Improvement Platform to Deliver LiveWell WorkWell Program 2Health News:Consumer Reports Poll: Most Say TV Drug Ads Should Include Info on How to Report Side Effects 2Health News:Consumer Reports Poll: Most Say TV Drug Ads Should Include Info on How to Report Side Effects 3Health News:New Scan 'Sees' Tumors Deep Inside Body 2
... premium high water content ... permeability. Standard one fit ... the following therapeutic conditions: ... bullous keratopathy, recurrent ulcers, ...
Guthrie fixation hook, sharp double prongs....
... lenses will feel good when you first put ... 12 hours later? Many lenses start to feel ... look blurry. But with Proclear lenses, youll enjoy ... This exceptional level of comfort is made possible ...
Designed to allow very easy handling....
Medicine Products: